Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmaceuticals

Set Alert for Pharmaceuticals

Are high costs blocking proper healthcare for companion animals?

Idaho-based pet medication supplier PetIQ believes the companion animal market in the US is set for healthy growth, despite the cost of medicine to owners proving to be a constant obstacle. Animal Pharm editor Joseph Harvey examined this dynamic and spoke to pricing specialist Graham Tatham of consultancy Simon-Kucher & Partners' animal health practice for his point-of-view.

Companion Animals Markets

KindredBio looking at several commercial options in Europe

Kindred Biosciences is looking at various commercial options as it aims for approval of its first product in Europe this year.

Kindred Biosciences Product Approvals

Potential sterility problems prompt Norbrook to recall products in US

Northern Irish company Norbrook Laboratories has recalled several lots of its injectable products in the US as a precautionary measure.

Norbrook Laboratories Policy & Regulation

DS Pharma gains extra approval for cattle injectable solution

The Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF) has approved an additional route of administration for DS Pharma Animal Health's Victas Injectable Solution 5% (orbifloxacin).

Product Approvals Pharmaceuticals

US FDA approves companion animal, livestock generics

The US FDA has recently handed out generic approvals to three companies for both livestock and pet products. 

Product Approvals Generics

ImmuCell achieves Re-Tain milestone, discusses potential setbacks

US firm ImmuCell has reached a key milestone in the development of its Re-Tain mastitis treatment. 

R&D Pharmaceuticals

Ceva close to EU approval for piglet injectable, Isemid authorized

Ceva Santé Animale has received a positive opinion ruling from European authorities for its Forceris antiprotozoal. 

Product Approvals Pharmaceuticals

Weakening antimicrobials continue to ring alarm bells, says new European report

The threat of antimicrobial resistance "shows no signs of slowing down", according to a report from leading European authorities.

Antimicrobial resistance Policy & Regulation

Agile Sciences to bring antibiotic-boosting molecules to animal health via Stonehaven Incubate

North Carolina's Agile Sciences has begun working with Stonehaven Incubate on introducing its pipeline to the animal health space.

Pharmaceuticals Deals

PetMedix snares sizeable series A to bring more antibody therapeutics to animal health

UK start-up PetMedix will begin drug discovery activities after securing £8 million ($10.4 million) in a series A funding round.

Investments Companion Animals

GeneQuine sets up new Berlin R&D site

German start-up GeneQuine Biotherapeutics has begun R&D activities at a new laboratory in Berlin. 

Operations R&D

Simparica and Cytopoint surpass $100m, with another blockbuster in Zoetis' pipeline

Zoetis now has 12 blockbuster products in its portfolio and believes another one is on the way.

Zoetis R&D
See All
Advertisement
UsernamePublicRestriction

Register